At a glance
ClinicalIndex Comparison RecordN/ACompleted· 25 enrolled
Drug / intervention
Tretinoin 0.05% cream +1 moredrug
Likely dose
Tretinoin 0.05% cream 25gfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
PHNA, Efficacy of Tretinoin Cream on Post-phototherapy Hyperpigmentation
In Brief
A clinical study evaluating Tretinoin 0.05% cream and Placebo cream for Vitiligo. Completed, enrolled 25 participants across 1 site.
Detailed Summary
A randomized controlled split-face pilot study was planned to investigate the preventive effect of tretinoin 0.05% cream on hyperpigmentation during phototherapy in patients with vitiligo.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsVitiligo
CountriesSouth Korea
Collaborators--
Timeline
N/ACompletedFinished
2020202120222023202420252026
Enrollment StartApr 2019
First PostedMay 2019
Primary CompletionNov 2019
Study CompletionNov 2019
TodayJul 2026
First PostedMay 1, 2019
Enrollment StartApr 29, 2019
Primary CompletionNov 19, 2019
Study CompletionNov 29, 2019
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 7.2 years ago
Interventions
Tretinoin 0.05% creamdrug
Stieva-A Cream 0.05%, 25g, GSK
Placebo creamdrug
Physiogel Daily Mositure Therapy Facial cream, 150mL, Stiefel